AMILI is a precision gut microbiome company based in Singapore, serving the region.
Through AMILI’s proprietary analytics engine, PRIME, they develop diagnostics tests, predictive algorithms and microbiome-modifying interventions.
Their consumer health arm, BIO & ME, utilizes insights from AMILI’s database and PRIME to generate Asia-centric solutions towards personalized diet, supplementation and precision health.
Please visit their website to learn more here: https://amili.asia/
